FUJIFILM Irvine Scientific Opens European Manufacturing Facility
• Qualification of new European hub in Tilburg, the Netherlands completed
• Facilities fully validated to support expanded capacity for cell culture media production
• Custom designed for sustainable operation
SANTA ANA, California, December 8, 2021: FUJIFILM Irvine Scientific, Inc., today announced that its new manufacturing facility in Tilburg, the Netherlands is now open and fully operational. The facility provides state-of-the-art Life Science manufacturing and joins locations in the U.S. and Japan to enable increased production capacity of cell culture media products; acting as a hub for both European and global markets.
Opening this third manufacturing facility fulfills an important step in the Company’s long-term plans to secure its production capacity to meet the growing needs of the market and customers worldwide. The facility’s location in central Europe positions it as a source of local supply for increased efficiency and cost-savings in shipping, as well as securing the supply chain.
The facility is built with sustainable initiatives in mind, drawing on parent company’s Fujifilm Sustainability Value Plan 2030 for sustainable operations. Strategies in use that adhere to the plan include working towards a CO2-neutral status, using wind energy for the production process, and using sustainable technologies such as membrane bioreactors for wastewater purification.
Set within FUJIFILM Manufacturing Europe B.V., one of the main production sites for FUJIFILM, the facility occupies approximately 13,500 square meters of space previously utilized to manufacture film rolls. The world-class facility manufactures dry powder media, liquid media, buffers, and Water for Injection (WFI) in accordance with the same Quality System, raw materials, and expertise used in the Company’s facilities in the U.S. and Japan. Initially, it increases the Company’s production capacity with approximately 320,000 kg/year of dry powder media and approximately 470,000 L/year of liquids with the physical capacity to expand rapidly.
"We worked steadily to achieve milestones for construction, validation, and commissioning of this manufacturing facility," said Yutaka Yamaguchi, chairman, and chief executive officer, FUJIFILM Irvine Scientific. "Even with the global challenges faced in recent years, FUJIFILM Irvine Scientific was determined to provide customers in Europe with local service that strengthens the supply chain and increases manufacturing capacity. It is extremely rewarding to see this commitment realized."
The site intends to become an ISO 13485 certified manufacturing facility and follow cGMP, 21 CFR 820 for product manufacturing. For more information about commercial manufacturing, please visit https://www.irvinesci.com/fujifilm-manufacturing-europe-bv.
View a video of the facility in action at https://www.youtube.com/watch?v=wC26NUG2gSs.
For high-res image contact firstname.lastname@example.org
Notes to Editors
FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific, Inc., is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivaled service and quality to scientists working in biopharmaceuticals, cell therapy, and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. FUJIFILM Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA, and Tokyo, Japan. The company’s consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 50 years, FUJIFILM Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services. FUJIFILM Irvine Scientific, Inc. is a subsidiary of FUJIFILM Holdings America Corporation reporting to FUJIFILM Holdings Corporation.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions and imaging products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2021, the company had global revenues of $21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
FUJIFILM Irvine Scientific
Phone: (949) 261-7800 x145
Phone: +44 (0)7891 477 378